Synlett 2014; 25(09): 1279-1282
DOI: 10.1055/s-0033-1341159
letter
© Georg Thieme Verlag Stuttgart · New York

Study of Oxidative Cyclization Using PhI(OAc)2 in the Formation of Benzo[4,5]thiazolo[2,3-c][1,2,4]triazoles and Related Heterocycles – Scope and Limitations

Charles S. Demmer*
a   Medicinal Chemistry Research, H. Lundbeck A/S, 9 Ottiliavej, 2500 Valby, Denmark
b   Chemical Neuroscience Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark   eMail: charles.demmer@sund.ku.dk   eMail: cdemmer15@gmail.com
,
Morten Jørgensen
a   Medicinal Chemistry Research, H. Lundbeck A/S, 9 Ottiliavej, 2500 Valby, Denmark
,
Jan Kehler
a   Medicinal Chemistry Research, H. Lundbeck A/S, 9 Ottiliavej, 2500 Valby, Denmark
,
Lennart Bunch
b   Chemical Neuroscience Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark   eMail: charles.demmer@sund.ku.dk   eMail: cdemmer15@gmail.com
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 14. März 2014

Accepted: 19. März 2014

Publikationsdatum:
28. April 2014 (online)


Abstract

A one-pot, two-step reaction for the synthesis of benzo[4,5]thiazolo[2,3-c][1,2,4]triazoles and related heterocycles under mild conditions was herein developed. The key step of this transformation is an oxidative cyclization employing PhI(OAc)2 as reagent. Scope and limitations (group functionality tolerance and sterics) were studied showing the robustness of the present methodology which can be used as potential access to new fused heterocycle libraries.

Supporting Information